3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
3
Turcot syndrome
2
Medulloblastoma
2
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Rhabdoid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Pinealoma
1
Peutz-Jeghers Syndrome
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Mouth Neoplasms
1
Locally Advanced Rectal Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Ependymoma
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Adenomatous Polyposis Coli
1
Interventions
toripalimab
2
pembrolizumab
2
Celecoxib
2
sintilimab
1
dostarlimab
1
camrelizumab
1
Radiation Dose Hypofractionation
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Interleukin-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Turcot syndrome
×
Celecoxib
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled